Allocation Concealment

The moment a trial can be biased before it starts

A trial can use a random number list and still be unfair. That is the specific catch behind allocation concealment. Randomization answers one question: what order should assignments follow? Allocation concealment answers a different question: can the recruiter see or guess the next assignment before deciding who gets in?

That timing matters. The bias happens before the participant is assigned. If a clinic worker knows the next person will receive a probiotic, creatine, placebo, or usual care, that knowledge can change who gets enrolled at that moment. A borderline participant may be included, delayed, or skipped. The change may be subtle and even well intentioned, but it can tilt the groups.

The surprise: blinding is too late to fix this

Many readers look for the phrase “double blind” and assume the trial is protected. Double blinding usually means people do not know which treatment someone received after assignment. Allocation concealment protects the step before assignment. These are different doors in the trial process.

A trial can be blinded but poorly concealed if the assignment list was visible, predictable, or kept in envelopes that could be opened early. A trial can also have good allocation concealment even if later blinding is impossible, such as a diet or exercise study. The Cochrane risk of bias guidance treats failures in this area as part of bias from the randomization process, because the problem is unequal starting groups, not expectation after treatment begins.

Good concealment uses practical barriers. Examples include a secure central randomization service, a pharmacy that releases the next coded bottle only after enrollment, or sequentially numbered, opaque, sealed envelopes prepared so they cannot be read or rearranged. CONSORT, the reporting standard for randomized trials, asks authors to report the mechanism used to implement the random sequence and the steps taken to keep it hidden until assignment.

Why reviewers care so much

This is not a paperwork preference. A major JAMA study found that trials with inadequate allocation concealment reported larger treatment effects than trials with adequate concealment. In that analysis, odds ratios were exaggerated by 41 percent when concealment was inadequate and by 30 percent when it was unclear. Later Cochrane work found that the size and direction of bias are hard to predict, but inadequate or unclear concealment remains a serious warning sign.

The word “unclear” is important. If a paper says “participants were randomized” but never explains how the next assignment was hidden, a careful reader should not give it full credit. Randomized is not the same as protected.

The one decision to make today

When you read a supplement trial, find the randomization section and look for the sentence that explains concealment. If it only says “randomized” or “computer generated,” treat the trial as less reliable than a trial that names a real concealment method, such as central randomization, pharmacy controlled assignment, or properly prepared sealed opaque envelopes. That single sentence can change how much trust the result deserves.

For supplement evidence, the specific failure mode to avoid is treating “computer randomized” as enough. A computer can create a fair list, but a visible fair list can still be misused during enrollment.